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Glyphosate is the functional component of the herbicide, RoundUp®. Although 
considered safe for humans by the US Environmental Protection Agency (EPA), it has 
been classified as “probably carcinogenic to man” by the International Agency for 
Research on Cancer (IARC). As such, the cellular effects of glyphosate require further 
study. This study was carried out to examine the role that glyphosate plays in altering 
human osteoblast cell function. We examined the effects of glyphosate (0.0007, 0.007, 
and 0.07 mg/ml) on human osteoblast cells (hFOB 1.19) for changes in proliferation rate, 
level of oxidative stress (ROS), glutathione (GSH) generation, and the expression of 
genes related to osteoblast differentiation and DNA methylation. This study was carried 
out to examine the role that glyphosate plays in altering human osteoblast cell function. 
Chronic glyphosate exposure caused a significant increase in proliferation in hFOB 1.19 
in a dose dependent manner. The lower concentrations of exposure had the greatest effect 
on proliferative rate, with 0.007 mg/ml having the most pronounced effect. Levels of 
cellular ROS and GSH remained unchanged following chronic exposure. Expression of 
the transcription factors Osterix and RUNX2, markers for osteoblast differentiation, 
showed no significant change relative to the control. Similarly, no significant change was 
observed in Osteocalcin, a bone-specific protein synthesized by osteoblasts and early 
marker of in vitro osteogenic differentiation. However, a trending increase was observed 
at the lowest glyphosate concentration of 0.0007 mg/ml. While no significant changes 
were observed in these markers for differentiation, a significant increase in osteoblast 
 
 
mineralization was observed at 0.0007 and 0.007 mg/ml. Further, by Day 7 of treatment, 
alkaline phosphatase activity was significantly increased across all treatment groups, 
indicating that glyphosate enhances osteoblast differentiation. The expression of each 
DNA methyltransferase (DNMT1/3a/3b), proteins that catalyze the addition of methyl 
groups to DNA, remained unchanged across all treatment groups. Finally, a significant 
increase was observed in global DNA methylation at 0.0007 mg/ml, suggesting that 
glyphosate is an effector of DNA methylation. While our current research is ongoing, the 
present findings indicate that glyphosate significantly alters osteoblast proliferation and 
differentiation in a dose dependent manner, however more research must be conducted to 
elucidate the molecular basis for these changes. This study contributes to the ongoing 
research into the potentially detrimental effects of glyphosate exposure on human health 
and provides a platform for future studies.
 
 
THE EFFECTS OF CHRONIC GLYPHOSATE EXPOSURE  




A Thesis Submitted to 
the Faculty of The Graduate School at  
The University of North Carolina at Greensboro 
 in Partial Fulfillment  
of the Requirements for the Degree  








Approved by                                                                                
____________________________ 
                                                                            Committee Chair 




This thesis written by Justin McGehee has been approved by the following 
committee of the Faculty of The Graduate School at The University of North Carolina at 
Greensboro. 
 
        Committee Chair 
   Karen Katula 
 
Committee Members 
   Zhenquan Jia 
    
    









Date of Acceptance by Committee 
 
_________________________ 







TABLE OF CONTENTS 
Page 
LIST OF FIGURES ........................................................................................................... iv 
CHAPTER 
I. INTRODUCTION .............................................................................................1 
II. MATERIALS AND METHODS .....................................................................14 
III. RESULTS ........................................................................................................22 






LIST OF FIGURES 
Page 
Figure 1. hFOB 1.19 Cell Proliferation Following Chronic Glyphosate  
Exposure .......................................................................................................23 
Figure 2. Low Level, Chronic Glyphosate Exposure Increases Alkaline Phosphatase 
(ALP) Activity in Differentiating hFOB1.19  
Osteoblasts ....................................................................................................25 
Figure 3. Low Level, Chronic Glyphosate Exposure Had No Significant Effect  
on the Relative Expression of RUNX2 (A), Osterix (B), or  
Osteocalcin(C-D) ..........................................................................................27 
Figure 4. Differentiated hFOB 1.19 Osteoblast Mineralization Following 21-Day 
Glyphosate Exposure ....................................................................................29 
Figure 5. Levels of Intracellular ROS in hFOB 1.19 Cells Following  
Chronic Glyphosate Exposure ......................................................................30 
Figure 6. Levels of Intracellular Glutathione in hFOB 1.19 Cells  
Following Chronic Glyphosate Exposure .....................................................31 
Figure 7. Gene Expression of Epigenetic Markers in hFOB 1.19 Osteoblast  
Cells Following Chronic Glyphosate Exposure ............................................32 













Herbicide exposure has been linked to various human diseases.  Glyphosate, the 
primary chemical component of the herbicide RoundUp®, is receiving increased scrutiny 
after it was found to be responsible for a case of non-Hodgkin’s lymphoma in a recent 
lawsuit (Benbrook, 2020). Moreover, it has been detected in common breakfast cereals 
such as Cheerios and Quaker Oats, as well as many common beer and wine products 
(Cook, 2019), indicating broad and consistent exposure.  Despite the global widespread 
use of glyphosate, the mechanistic pathways in which glyphosate alters cellular function 
are not well defined. Current research suggests that exposure to glyphosate leads to an 
increase in the generation of reactive oxygen species (ROS), perpetuating cellular 
oxidative stress.  Increased ROS is known to cause DNA damage and negatively affect 
proteins and lipids.  In addition, alterations to the epigenome, more specifically, increased 
DNA methylation, may occur in response to increased oxidative stress, leading to 
changes in gene expression. 
The goal of this research is to further investigate the cellular consequences of 
chronic glyphosate exposure.  A normal osteoblast cell line hFOB1.19 was chosen as a 
model to allow for studying how glyphosate exposure can impact not only basic cell 
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functions but also cellular differentiation.  In addition, there are no published results of 
glyphosate effects on osteoblast cells and differentiation. We hypothesized that 
hFOB1.19 cells chronically exposed to glyphosate display altered levels of ROS and 
glutathione, changes in global genomic DNA methylation, and modifications in the level 
of osteoblast differentiation markers. 
 
Glyphosate Use 
Glyphosate is a broad-spectrum organophosphorus herbicide and is the primary 
chemical component Roundup®. It is widely available in many chemical forms for both 
agricultural use and use in home gardens. In plants, glyphosate functions to inhibit the 
shikimate pathway, a pathway responsible for the synthesis of the amino acids 
phenylalanine, tyrosine, and tryptophan. Through the inhibition of 5-
enolpyruvylshikimate-3-phoaphate, the essential downstream amino acids are no longer 
synthesized in growing plants, eventually leading to plant death. It is a pathway that is 
unique to plants and not found in the mammalian genome (NPIC, 2019).  
Since the development of “Roundup Ready” crops in 1996, glyphosate has 
become the most widely used herbicide globally. A recent study notes that from 1974 to 
the present, 1.6 billion kilograms of glyphosate has been applied in the United States, 
two-thirds of which was applied in the last 10 years (Benbrook, 2016). This accounts for 
nearly 20% of estimated global glyphosate use (8.6 billion kilograms). Despite the 
availability of “Roundup Ready” crops, the excessive use of glyphosate has led to 
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resistant weeds, requiring more frequent application of herbicides to crops and gardens. 
Through this widespread use, detectable levels of glyphosate have been identified in 
soils, groundwater, and precipitation and recently cereals, beers, and wines (Battaglin et 
al., 2014). This indicates that human exposure to glyphosate is not limited to those who 
work in agricultural industries. 
The current regulatory requirements for the applications of glyphosate are nearly 
30 years old. Despite the fact that the Environmental Protection Agency (EPA) has 
established an “acceptable” exposure level of 0.0007 mg/ml, the World Health 
Organization’s International Agency for Research on Cancer (IARC) has recently marked 
glyphosate as “probably carcinogenic to man” (IARC, 2015). As a result of increased 
scrutiny, the EPA reviewed the carcinogenic potential of glyphosate in 2016 and 
concluded that it was “not likely to be carcinogenic to humans”, only one year later. 
These designations have reignited a need for continued research into glyphosate’s effects 
on human health.  
 
Glyphosate – Organismal and Cellular Effects 
The organismal and cellular effects of glyphosate have been studied broadly. 
While glyphosate is currently considered a non-toxic herbicide due to its low LD50, 
multiple studies have linked glyphosate exposure to changes in cellular function. In 2013, 
glyphosate was shown to increase the proliferative rate of human breast cancer cells 
T47D through the induced activation of estrogen response element transcription activity. 
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This suggests that glyphosate has a potential effect on proliferative rate, serve as an 
endocrine disruptor, and effect gene transcription at environmentally relevant 
concentrations (Thongprakaisang et al., 2013). A similar study into the effects of 
glyphosate on cellular function showed that a commercial formulation of glyphosate 
inhibits the proliferation of fibroblasts, indicating that the observed effects may be cell 
type specific (Martini et al., 2012). And more recently, glyphosate exposure was found to 
cause a disturbance in the morphology of thyroid cell structure in Wistar rats, again 
showing its effect as an endocrine disruptor (Hamdaoui et al., 2020). Relevant to our 
current study, a perturbation of bone metabolism was observed in this study, revealing 
that glyphosate exposure may influence bone cells specifically. They observed the 
thinning and discontinuity of bone trabecular, indicating that there may be an effect on 
osteogenesis.  
  
Glyphosate – Effects on Human Health and Cancer 
Various human cell lines have been used as a resource for investigating the effects 
of glyphosate exposure. As early as 1980, the toxic effects of glyphosate were evaluated 
in human lymphocytes (Vyse et al., 1980). In this study, they focused on the Sister-
Chromatid Exchange index (SCE), a means of quantifying the mutagenic effect of 
glyphosate. While they were able to show a significant increase in the SCE index, it was 
only observable at higher levels of exposure (0.1 mg/ml). Within the last decade, many 
more studies were conducted on the genotoxic potential of glyphosate in lymphocytes. A 
5 
 
2009 study observed the effects of glyphosate at environmentally relevant concentrations 
(3.5 µg/ml); those likely to be observed when used occupationally or residentially 
(Mladinic et al., 2009). Their results indicated that there was no effect of glyphosate on 
any assay applied in their study, leading them to conclude that glyphosate poses no 
significant risk to human health based on current usage. Contrary to these results, a more 
recent 2014 study was able to show glyphosate (0.7 µM – 7 µM) does induce a genotoxic 
effect in a dose-dependent manner on human lymphocytes (Alvarez-Moya et al., 2014). 
While the effects are not limited to a specific cell type, these studies illustrate the degree 
in which results may vary depending on treatment condition and chemical formulation. 
Because of this, there is generally no consensus on the effects of glyphosate on healthy 
human cells. 
Within the last decade, multiple studies have evaluated the carcinogenic potential 
of glyphosate using varying tumor cell lines. In a study discussed previously, glyphosate 
caused proliferative effects on human breast cancer cells TD47 (Thongprakaisang et al., 
2013). This was attributed to changes in estrogen receptor (ER) expression as a result of 
48-hour exposure to glyphosate. A 2019 study investigated gene expression changes of 
common canonical pathways in both ER positive and ER negative breast cancer cell lines 
(Stur et al., 2019). They found that both cell lines displayed changes in the expression 
patterns of 11 canonical pathways, including those responsible for cell cycle and DNA 
damage repair. As these changes were seen in both ER positive and ER negative cell 
lines, the authors concluded that the dysregulation was the result of a multitude of 
molecular and cellular effects, and not solely endocrine disruption. The effects on cell 
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cycle and DNA damage repair ultimately were found to lead to the accumulation of 
mutations and cell death. 
There are many recent studies investigating the link between glyphosate exposure 
and cancer development. In 2019, Monsanto, the company that produces Roundup®, was 
found liable in a lawsuit from an individual diagnosed with non-Hodgkin lymphoma. As 
a cause of cancer, multiple groups have studied the link between the development of non-
Hodgkin lymphoma and glyphosate exposure, none of which found a statistically 
significant association. In 2019, data was gathered from AgriCan, the Center for Novel 
Agricultural Products (CNAP), and Agricultural Health Study (AHS). This data linked 
country-specific crop-exposure matrices to extrapolate overexposure to many pesticides 
and herbicides, including glyphosate. In this epidemiological study, they did find a 
moderately elevated positive meta-hazard ratio (HR = 1.36; p < 0.05) between diffuse 
large B-cell lymphoma and glyphosate exposure (Leon et al., 2019). In conclusion, the 
link between glyphosate exposure and cancer remains debatable. 
 
ROS Involvement in Glyphosate Exposure 
Reactive oxygen species (ROS) are formed during normal cellular metabolism 
and have important functions in cellular signaling and homeostasis. These ROS species 
include the superoxide anion, peroxide, hydrogen peroxide, hydroxyl radicals, and 
hydroxyl ions. While reactive oxygen species are a natural byproduct of normal oxygen 
metabolism, during periods of environmental stress ROS levels can increase and result in 
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damage to cellular structure, whether it be damage to DNA, RNA, proteins, or lipid 
peroxidation. The effects of increased reactive oxygen species have been commonly 
implicated in various physiological states including cancer, infertility, and ageing. 
Hydrogen Peroxide, for example, is a known major contributor to oxidative damage. As 
superoxide leaks from mitochondria through electron leak from the electron transport 
chain, it will undergo dismutation into hydrogen peroxide, which is later converted into 
water. The conversion process from hydrogen peroxide to water is not completely 
efficient in a cell under basal levels of oxidative stress, allowing peroxide radicals to 
remain (Jastroch et al., 2010). During periods of increased oxidative stress, excess 
amounts of these ROS species can cause deleterious effects. The oncogenic properties of 
ROS provide an interesting model for how increased oxidative stress can facilitate cancer 
cell survival. Moderate amounts of ROS are required for cell cancer survival. Growth 
factors that drive cell-cycle progression often require ROS as a second messenger for 
activation (Sundaresan et al., 1995). This allows for a potential increase in proliferation 
for cancer cells. 
 A recent in vivo study of glyphosate on Caenorhabditis elegans was conducted 
using various concentrations of a glyphosate containing herbicide, TouchDown® (Bailey 
et al., 2018). While these studies used higher concentrations of glyphosate than we plan 
to use in our study, it was determined that there was a significant increase in hydrogen 
peroxide production, likely due to the increased oxidative stress and mitochondrial 
inhibition. Other studies linked DNA damage to increased oxidative stress in human 
peripheral blood mononuclear cells when exposed to glyphosate (Woźniak et al., 2018). 
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The same study showed an increase in sequence specific DNA methylation, specifically 
in the p53 promoter region. Importantly to our study, it has previously been demonstrated 
that the commercial formulation of Glyphosate (RoundUp®) caused an increase in levels 
of reactive oxygen species at dilution levels far below agricultural recommendations 
(Chaufan et al., 2014). In this study, the effects of glyphosate on oxidative stress were 
measured in HepG2 cell line through the use of H2DCFDA, a probe used to detect 
multiple forms of free radicals/reactive species (OH, ONOO-, H2O2, NO, and ROO). 
Typically, agricultural products are supplied in a formulation of 360 g/L of acid 
glyphosate (RoundUp®). This study was able to show dose-dependent cytotoxicity at a 
concentration of 0.04 mg/ml of acid glyphosate formulation, much lower than what 
would be commonly found in agricultural products, although greater than the EPA 
acceptable exposure level. 
 
ROS and Epigenetic Modifications 
The DNA Methyltransferase (DNMT) family of proteins work to catalyze the 
transfer of methyl groups (CH3) to DNA. There are two major DNMTs we are analyzing, 
each of which serve a unique function. DNMT1 is responsible for maintaining 
methylation patterns in proliferating cells. During replication, the daughter strand lacks 
the methylation patterns of the parent strand. DNMT1 binds to these hemi-methylated 
sites, allowing the addition of a methyl group to the cytosine on the daughter strand, thus 
conserving the established methylation pattern. DNMT3a functions to provide de novo 
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methylation. These proteins do not require the same hemi-methylated strands to bind, 
although, they are able to act on these sites, as well as unmethylated CpG islands. This 
allows for genome wide de novo methylation, leading to potential gene repression. 
DNMT3a functions primarily during embryogenesis when the methylation patterns of the 
embryos are re-established. 
Genomic DNA methylation has multiple functions. It is involved in X-
chromosomal inactivation, imprinting, transposon silencing, and gene regulation (Jin et 
al., 2011). Increased DNA methylation within CpG islands of gene promoters inhibit 
gene transcription. Generally, gene associated CpG islands are unmethylated, however, 
abnormal DNA methylation, such as that due to changes in DNMT activity, can lead to 
aberrant gene expression. 
Cellular damage caused by reactive oxygen species (ROS) leads to varying 
degenerative processes within the cell. As previously mentioned, there is a delicate 
balance between ROS production and scavenging under normal physiological conditions. 
If this balance is disturbed via the introduction of xenobiotic compounds into the cellular 
environment, cellular stress mounts and degenerative processes begin to occur. One of 
the byproducts of increased oxidative damage is the modification of DNA methylation 
(5-mC) patterns. The most common epigenetic variance in cancer cells is abnormal DNA 
methylation patterns. These DNA modifications are cancer type dependent and can 
manifest as global demethylation or hypermethylation (Lokk et al., 2014). Increased ROS 
has been shown to activate NF-κB and to bind and activate DNMT1 expression (Hong et 
al., 2013). It has also been proposed that increased ROS can lead to both hypo- and 
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hypermethylation in precancerous cells due to increased DNMT1 activity (Wu et al., 
2015). A more recent study has shown that demethylation in glioma tissue was a direct 
result of the increased reaction of hydroxyl radicals with DNA (Barciszewska et al., 
2019), further establishing a link between ROS and epigenetic modifications. 
 
Glyphosate – Epigenetic Effects 
Previous studies have shown that glyphosate leads to a decrease in the expression 
of DNA methyltransferase, potentially altering global methylation patterns (Smith et al., 
2019). In this study, Oryzias latipes were exposed to environmentally relevant levels of 
glyphosate (0.0005 mg/ml) and the expression of DNMT1 was quantified through qPCR. 
The expression of methylcytosine dioxygenase genes (Tet1, Tet2, and Tet3) were also 
quantified in this study. While DNMT1 was shown to decrease, the expression of 
methylcytosine dioxygenase genes increased. Presumably, these changes could 
potentially lead to alterations in global DNA methylation patterns. 
The epigenetic effects of glyphosate exposure are sparsely documented in both in 
vivo and in vitro studies, though many existing studies reach similar conclusions. A 
recent study investigated the effects of glyphosate exposure in non-neoplastic MCF10A 
mammary epithelial cells (Duforestel et al., 2019). In this study, the MCF10A cells were 
exposed to low-dose glyphosate (10-11 M) chronically for 21 days. They reported a 
reduction in 5-mC content in chronically treated MCF10A cells, concluding that 
glyphosate promotes global DNA hypomethylation. 
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Glyphosate induced hypomethylation of DNA has also been observed in human 
peripheral blood mononuclear cells (PBMCs) (Woźniak et al., 2020). This study 
investigated the epigenetic potential of low-level glyphosate (0.5 µM – 100 µM) over a 
24-hour period. Despite a shorter treatment period, this study found a significant decrease 
in global DNA methylation in all treatment groups. The results from this study seem to 
correlate with similar studies regarding the effects epigenetic potential of glyphosate 
exposure, regardless of cell line, organism, and treatment duration. 
 
Osteoblasts as a Model for Investigating the Cellular Effects of Glyphosate 
hFOB 1.19 cells are SV40 large T antigen transfected human osteoblasts. These 
cells provide a rapidly proliferating model system and are ideal for studying human 
osteoblast differentiation (ATCC 2020). hFOB 1.19 cells are well-characterized and 
methods for inducing differentiation are well established. The osteoblast cell lineage is 
subject to epigenetic modification, particularly DNA methylation changes, during 
transformation (Kresse et al., 2012). Understanding the effects of glyphosate on 
osteoblast proliferation and differentiation is important, as it may reveal a potentially 
negative effect on bone tissue dynamics with consequences to human health, outside an 





Project Overview and Specific Aims 
Herbicide exposure has been linked to various human diseases and conditions and 
there is mounting evidence that an individual’s accumulated environmental exposure is 
reflected in their epigenome. Glyphosate has the potential to negatively affect cell 
viability and function, including the cell’s ability to proliferate and differentiate, 
ultimately leading to adverse health effects. Current studies show that glyphosate 
exposure has the potential to increase cellular oxidative stress (Chaufan et al., 2014). 
Significantly, it has been shown that increased oxidative stress can alter DNA 
methylation (Duforestel et al., 2019). Currently, there is a lack of understanding 
regarding how glyphosate impacts cell function. The goal of this study is to provide 
experimental evidence outlining the mechanistic effect of glyphosate on cellular function 
and to broaden the understanding of the role that epigenetics plays these changes. 
 
Aim 1: Determine the dose-dependent effects of chronic glyphosate exposure on 
cell proliferation and differentiation in the human osteoblast cell line hFOB1.19. 
 
Aim 2: Measure the levels of oxidative stress using ROS and Glutathione in 




Aim 3: Determine changes in gene expression of DNA Methyltransferase and 






MATERIALS AND METHODS 
Cell Culture and Differentiation 
hFOB 1.19 SV40 large-T immortalized human fetal pre-osteoblast cells were 
obtained from the American Type Culture Collection (ATCC® CRL-11372™). The cells 
were cultured in a medium consisting of Dulbecco’s Modified Eagle Medium: Nutrient 
Mixture F-12 (DMEM/F12) supplemented with 0.3 g/L G418 (Geneticin), 10% fetal 
bovine serum, and 0.1 g/L penicillin-streptomycin. The cells were grown in T-75 flasks 
in a humidified incubator at a temperature of 34.4°C with 5% CO2. Growth media was 
renewed ever 2-3 days. The cells were allowed to reach 80-85% confluence before being 
split. Differentiation was induced by first growing the cells to confluency and then by 
adding a differentiation medium containing a mixture of 0.1 g/L ascorbic acid, 5 x 103 
mol/L β-glycerol phosphate, 108 mol/L menadione, and 10-7 25(OH)2D3 vitamin D. The 
cells are grown in a 39°C incubator with 5% CO2. 
 
Chronic Glyphosate Exposure 
 A 10 mg/ml glyphosate stock was prepared in water and filter sterilized through a 
0.2 mM filter. hFOB 1.19 cells were plated at 2.2 x 106 per 100 mm dish and treated with 
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0.0, 0.0007, 0.007, and 0.07 mg/ml glyphosate. The cells were allowed to grow to 85-
90% confluence, collected, counted, and re-plated at the same cell density. Glyphosate 
was added directly to the medium at each passage. Cell cultures were maintained in 
humidified incubator at 34.4°C with 5% CO2 for the duration of their exposure period of 
four weeks. Cells were collected, resuspended in complete medium containing 5% 
DMSO and stored in liquid nitrogen. These cell stocks were considered “chronically 
exposed” hFOB 1.19 cells and were used for the various assays. 
 
Proliferation Assay 
hFOB 1.19 cells that were chronically treated with glyphosate for at least four 
weeks were grown in 100 mm plates for 2-3 days. The cells were collected and each 
treatment group re-plated at 1 x 103 in 96-well plates. Each assay day and treatment 
group included six replicas (n=6). The day after plating, the cells were considered at Day 
0. Cell numbers were determined by measuring DNA content using the CyQuant NF Cell 
Proliferation Assay Kit (Invitrogen™ C35006). To assay for DNA content, medium was 
removed from the cells and 50 µl of DNA binding dye was pipetted to each well. The 
cells were incubated for 35 minutes at 34.4ºC to allow binding of the dye. Fluorescence 
was measured at a wavelength of 485/525 nm using the Synergy™ 2 Multi-Mode 
Microplate reader. DNA assays were repeated on days 0, 3, 4, 5, 6, and 7. Glyphosate 
concentrations were maintained in the medium during the entire period. Medium was 
changed one time during the seven-day period. Data was analyzed by standardizing the 
16 
 
DNA values of each individual treatment group to the Day 0 value. This controls for 
slight variations in starting cell number. 
 
Alkaline Phosphatase Assay 
Alkaline phosphatase (ALP) activity was measured as a determination of hFOB 
1.19 differentiation, as levels of ALP increase during this process. Cells from each 
treatment group were plated in 96-well plates at a density of 1x104 to allow for 
confluence after a two-day period. A separate plate was prepared for each time point 
(Day 0, 3, 7). N=6 for each treatment group and day. In addition, extra wells were 
included for DNA assay. Differentiation medium containing β-glycerol phosphate, 
ascorbic acid, menadione, and vitamin D were added to the cells on Day 0 to induce 
differentiation, as previously described. At each time point, medium was removed from 
the cells and washed with 1x PBS and stored at -80ºC. An ALP assay buffer containing 
10.5 mg/ml diethanolamine (DEA), 0.1% Triton X-100 was prepared. To assay for ALP 
activity, 80 µl of the substrate solution containing 1 tablet of p-nitrophenyl phosphate 
(pNPP) per 2.7 ml of assay buffer was added directly to each well of the plate. The cells 
were incubated for 60 minutes in the dark at room temperature. 20 µl of stop solution 
(100 mM NaOH) was added to each well to halt the reaction. Samples were read at O.D. 
405 using the Synergy™ 2 Multi-Mode Microplate reader. DNA content was determined 
using the CyQuant NF Cell Proliferation assay as previously described. Fluorescence was 
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standardized to DNA content for each treatment group. Fold-Change was relative to Day 
0. 
 
RNA Extraction and cDNA Synthesis 
 For analysis of differentiating cells, the chronically exposed hFOB 1.19 cells were 
collected and re-plated at a density of 7.5 x 104 cells per well of a 6-well plate. When the 
cells reached confluence, the medium was replaced with differentiation medium (see Cell 
culture and Differentiation) plus the appropriate amount of glyphosate. At Days 0, 3, and 
7, cells were washed with 1x PBS and taken-up in RNA lysis buffer (Zymo Research 
R1060-1-100). The lysates were frozen at -80ºC. RNA was purified from the lysates 
using the Zymo Quick-RNA MiniPrep kit (Zymo Research R1051). RNA isolation from 
the nondifferentiated chronically exposed cells followed the same procedure. 
 cDNA was synthesized using the SuperScript™ IV First-Strand Synthesis System 
kit (Invitrogen™). A total of 1 µg of RNA was used in each reaction equaling a total of 
20 µl cDNA per sample. Each cDNA sample was diluted with 20 µl RNase free water. 
The resulting cDNA was stored at -20ºC prior to qRT-PCR analysis. 
 
Quantitative Real-Time Polymerase Chain Reaction (qPCR) 
 cDNA samples from each treatment group for the different studies were used in q-
PCR analysis. For osteoblast differentiation, the following were analyzed: RUNX2 
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(Thermo Fisher Hs01047973_m1), Osterix (Thermo Fisher Hs01866874_s1), and 
Osteocalcin (Thermo Fisher Hs01587814_g1) with Actin (Thermo Fisher 
Hs00157387_m1) used as an internal control. In a separate q-PCR study, each sample 
was probed for DNMT1 (Hs00945875_m1) and DNMT3a (Hs01027162_m1), enzymes 
required for DNA methylation. TaqMan probes were used for each reaction. The standard 
PCR reaction consists of 5 µl of 2x TaqMan buffer (Applied Biosystems 4304437), 3.5 µl 
of ddH2O, and 0.5 µl of primer, and 1 µl cDNA. A master mix for each common primer 
was prepared. The amplification process was carried out using the Applied Biosystems™ 
StepOnePlus™ Real-Time PCR system in the following protocol: 95°C for 20 seconds 
followed by 40 cycles alternating between 95°C for 3 seconds and 60°C for 30 seconds. 
To quantify expression levels, relative fold-change was determined comparing actin 
standardized comparative threshold (Ct) values of each treatment group to the 0.0 mg 
control to generate a Log2 ΔΔCt value. 
 
ROS Assay 
 ROS activity was measured using the chemical dichloro-dihydro-fluorescein 
diacetate (DCFH-DA), a fluorescent dye that measures the presence of hydroxyl, peroxyl, 
and multiple other reactive oxygen species (Sigma-Aldrich D6883). The compound 
enters the cell and becomes deacetylated and subsequently oxidized by intracellular ROS 
species into 2’, 7’ -dichlorofluorescein (DCF), which fluoresces at wavelength 485/525 
nm. A 5 mM stock of DCFH-DA solution was prepared using 1x PBS. hFOB 1.19 cells 
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were chronically treated with 0, 0.0007, 0.007, 0.07 and 0.7 mg/ml glyphosate for a 
period of 4 weeks. The cells were collected and re-plated in 96-well culture plates (n=12 
for each treatment group) and allowed to adhere overnight. Additional wells of the same 
cells for each treatment group were plated at the same time for DNA content analysis 
(n=12). The following day, the medium was removed, cells were washed with 1x PBS, 
and 100 µl of 50 mM DCFH-DA solution was added to each well. The cells were 
incubated at 34ºC for 30 minutes and read at 485/535 nm using the Synergy™ 2 Multi-
Mode Microplate reader. To ensure equal cell number, DNA levels were quantified in the 
additional wells using CyQuant NF Cell Proliferation Assay kit (Invitrogen™). hFOB 
1.19 cells were plated at the same density, received the same treatment, and were cultured 
in the same conditions as the cells assayed for ROS activity. The ROS fluorescence 
values were standardized to DNA content. 
 
Glutathione Assay 
 Glutathione (GSH) levels were quantified through the use of the Invitrogen™ 
fluorometric dye monochlorobimane (Thermo Fisher M1381MP). When bound to 
reduced or oxidized glutathione, MCBI will fluoresce at 360/460 nm. A stock 11.05 mM 
MCBI solution was prepared in DMSO. Prior to adding the solution to the cells, a 50 µM 
dilution is prepared in 1x PBS. hFOB 1.19 cells were plated, treated, and grown under the 
same conditions as the cells used for the ROS assay described above (n=12). Following 
overnight adhesion, the cells were washed with 1x PBS and 100 µl of MCBI was added. 
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The cells were incubated at 34ºC for 30 minutes and read 360/460 nm using the 
Synergy™ 2 Multi-Mode Microplate reader. The same wells assayed for DNA content as 
described for the ROS assay were used for the Glutathione assay. 
 
5-mC ELISA Assay 
hFOB 1.10 cells were chronically treated with the different concentrations of 
glyphosate for four weeks. At 85-90% confluence, the cells were washed with 1x PBS 
and collected in 15 mL falcon tubes. The cells were pelleted by centrifugation, the 
supernatant was removed, and the cell pellets were used for isolation of genomic DNA. 
Pellets were stored at -80ºC until use. Genomic DNA was extracted from the cells using 
the Quick-DNA Magbead Plus kit (Zymo Research D4081). Levels of gDNA were 
quantified using a Thermo Scientific™ Nanodrop 2000. DNA methylation was quantified 
using the Zymo Research™ 5-mC DNA ELISA kit (D5326) and protocol. Exactly 100 ng 
of gDNA was used per well in the ELISA. 
 
Alizarin Red Staining 
The cells were grown to confluence at which time the medium was replaced with 
differentiation medium. Glyphosate concentrations were maintained during the course of 
the study. Cells were grown under differentiation conditions for 21 days prior to assay. 
The cells were plated on a 12-well culture dish at a density of 1 x 105 and allowed to 
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grow to confluence. Once confluent, growth medium was replaced with differentiation 
cocktail containing glyphosate. The cells were incubated for 21 days in a humidified 
incubator at 39ºC with 5% CO2. The differentiation cocktail was refreshed every 3-4 days 
for the duration of the experiment. 
After the 21-day period, the bone matrix was stained with the Alizarin Red S 
Staining Kit (ScienCell Research Laboratories Cat. #0223). The cells were fixed with 4% 
formaldehyde, stained for 30 minutes with 40 mM ARS solution, and washed 5x with 
diH2O. The plates with the stained cells were stored at -20ºC until use. The cells were 
collected using a cell scraper in 400 µl of 10% acetic acid. All samples were heated to 
85ºC for 10 minutes. A volume of 150 µl of 10% ammonium hydroxide was used to 
neutralize the acid. An aliquot of 150 µl of each sample was plated in triplicate on a 96-




 Individual assays included at least three technical replicas and for some assays 6-
12 replicas. Standard error was determined for all data sets. For some assays, three 
independent trials were carried out and the data combined by averaging the three values. 






Effects of Chronic Glyphosate Exposure on hFOB 1.19 Proliferation 
 To evaluate the effects of chronic glyphosate exposure on non-differentiated 
hFOB 1.19 cell proliferation, cells that were exposed to 0.0, 0.0007, 0.007, and 0.07 
mg/ml glyphosate for at least four weeks were grown in the presence of glyphosate over a 
7-day period. On days 0, 3, 4, 5, 6, and 7, a set of cells (n=6) from each treatment group 
were stained with a fluorometric dye that binds nucleic acid. Emitted light values are 
proportional to the number of cells, allowing for quantification of cell proliferation over 
time. The values at each day were standardized to Day 0 for each treatment group. This 
controlled for slight variations in cell number at plating. 
 At Day 3, proliferation at 0.0007 mg/ml was significantly lower than our control. 
By Day 4, we found a similar lower rate in both 0.07 and 0.0007 mg/ml and remained 
significantly lower through Day 5. By Day 6, a significant increase in proliferation was 
observed at 0.0007 mg/ml, while 0.07 mg/ml now showed no difference from the control 
group. On the 7th day, there was no significant difference between control group and the 
0.0007 and 0.07 mg/ml treatment groups. Interestingly, beginning on Day 4, the 0.007 
mg/ml group showed a significant increase in cell proliferation that remained increased 
throughout the duration of the study. The increase in proliferation of the 0.007 mg/ml 
treatment groups was confirmed in three independent trials. These results suggest that 
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chronic exposure of hFOB 1.19 osteoblasts to low levels of glyphosate, including the 
EPA exposure limit, positively effects proliferation. Though there was an initial decrease 
in proliferation at 0.0007 and 0.07 mg/ml, these differences was stabilized by the end of 
the study, with 0.0007 mg/ml increasing significantly as it progressed. The trend in 
proliferation seems to be in an inverted U shape, indicating that the trend is non- 
monotonic. 
 
Figure 1. hFOB 1.19 Cell Proliferation Following Chronic Glyphosate  
Exposure. Low level, chronic glyphosate exposure has a positive effect on hFOB1.19 
osteoblast proliferation. hFOB1.19 were treated with 0.0, 0.0007, 0.007, and 0.07 mg/ml 
for at least one month. Cells were plated at a low concentration in 96-well plates. DNA 
content was measured from Day 0 to Day 7, as a measure of cell number. Values are 
expressed relative to Day 0 for each treatment group. Asterisks indicate significance 
(p<0.05) comparing the treatment group to the control for that day. N=6 for each 
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Effects of Chronic Glyphosate Exposure on Osteoblast Cell Differentiation 
Next we determined if chronic glyphosate exposure effected osteoblast 
differentiation. Three markers of differentiation were measured: level of alkaline 
phosphatase (ALP) activity, expression of genes associated with differentiation, and 
accumulation of extracellular bone matrix. 
ALP Activity 
 We measured ALP activity in chronically exposed hFOB 1.19 osteoblasts induced 
to differentiate. Cells were assayed at Days 3 and 7 (Fig. 2A/2B). At Day 3, APL levels 
in the 0.0007 and 0.007 mg/ml treated cells are no different from the control, whereas 
there was a significant decrease in the 0.07 mg/ml cells. In contrast at Day 7, there is a 
significant increase in ALP activity in hFOB 1.19 cells exposed to glyphosate, at all 
experimentally relevant concentrations (0.0007, 0.007, and 0.07 mg/ml), relative to an 
untreated control. There was a visible dose-dependent effect on alkaline phosphatase 
activity on day 7, whereas the lowest concentration of glyphosate caused the greatest 
increase in ALP activity. These results suggest that chronic glyphosate exposure 




Figure 2. Low Level, Chronic Glyphosate Exposure Increases Alkaline Phosphatase 
(ALP) Activity in Differentiating hFOB1.19 Osteoblasts. hFOB1.19 cells exposed for 
at least one month to 0.0, 0.0007, 0.007, and 0.07 mg/ml glyphosate were plated under 
differentiation conditions. At Days 3 (A) and 7 (B) and cells were assayed for ALP 
activity. ALP activity was standardized to DNA content, as a measure of cell number and 
fold-change relative to Day 0 for each treatment group plotted. Asterisks indicate 
significance (p<0.05) relative to the control. N=12 for each treatment group. 
 
 
Expression of Differentiation Associated Genes 
 To further determine the effects of chronic glyphosate exposure on hFOB 1.19 
cells, q-PCR analysis of the expression of three genes associated with differentiating 
osteoblasts was performed. By Day 3, mRNA levels for RUNX2 and Osterix, 
transcription factors required for determination of the osteoblast lineage and early 
markers for osteoblast differentiation, were statistically the same between each of the 
treatment groups (0.0007, 0.007, and 0.07 mg/ml) relative to the control (Fig. 3A/B). 
However, a trend in decrease in osterix transcript levels were noted for all three 
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solely by osteoblasts, was also found not to be significantly different, comparing each 
treatment to the control on Day 3 or Day 7 (Fig. 3C). However, at both Days 3 and 7, 














Figure 3. Low Level, Chronic Glyphosate Exposure Had No Significant Effect on 
the Relative Expression of RUNX2 (A), Osterix (B), or Osteocalcin(C-D). hFOB 1.19 
were chronically treated with glyphosate for at least four weeks prior to the induction of 
differentiation. Glyphosate levels were maintained throughout the differentiation process. 
Relative fold-change was determined comparing actin standardized comparative 
threshold (Ct) values of each treatment group to the 0.0 mg control to generate a ΔΔCt 
value. Each resulting value was divided into the control for the given day to generate 
fold-change relative to the control. Data are representative of three independent q-PCR 




























































































Extracellular Matrix Assay 
 The level of extracellular matrix calcium was assayed as an indication of 
advanced osteoblast differentiation. hFOB 1.19 cells were allowed to grow in the 
presence of glyphosate for at least four weeks. These chronically treated cells were 
collected, counted, and re-plated on 12-well plates (N=3) and allowed to reach 
confluence. Once confluent, differentiation was induced as previously described and the 
cells were grown for a period of 21 days. Differentiation medium was replaced every four 
days and glyphosate levels were maintained for the duration of the experiment. At day 
21, the cells were stained with Alizarin Red S. 
Extracellular calcium deposits were observed 3-weeks post osteogenic induction. 
Differentiated hFOB 1.19 cells stained red represent positive Alizarin Red S Staining, 
indicating mineralization. At Day 21, hFOB 1.19 osteoblasts showed a significant 
increase in mineralization at 0.0007 and 0.007 mg/ml, while there was no difference at 
0.07 mg/ml relative to the control (Fig. 4). These results suggest that chronic, low level 




Figure 4. Differentiated hFOB 1.19 Osteoblast Mineralization Following 21-Day 
Glyphosate Exposure. Osteogenic differentiation was induced in hFOB 1.19 cells 
chronically exposed to 0.0, 0.0007, 0.007, and 0.07 mg/ml glyphosate for 4 weeks. 
Differentiating cells were grown for 21 days in the presence of glyphosate. The cells 
were assayed by Alizarin Red Staining for to measure mineralization. Shown is the 
average O.D. 405 nm (n=3). Asterisks indicate significance (P<0.05). 
 
 
ROS Activity in hFOB 1.19 Cells Chronically Exposed to Glyphosate 
Levels of reactive oxygen species (ROS) were measured following 4-week 
chronic glyphosate exposure using dichloro-dihydro-fluorescein diacetate (DCFH-DA). 
Because of the transitory and short-lived nature of ROS species, levels of intracellular 
ROS may vary between assays, however, the results from three independent assays were 
combined. In the current study, we found that hFOB 1.19 cells show no significant 
differences in ROS activity following 4-week chronic glyphosate exposure when 
compared to a control group (Fig. 5). DNA content of these cells was measured, and 




































Figure 5. Levels of Intracellular ROS in hFOB 1.19 Cells Following Chronic 
Glyphosate Exposure. Activity of reactive oxygen species (ROS) in proliferating hFOB 
1.19 cells shows no significant difference following chronic glyphosate exposure. 
Following 4-week chronic exposure, hFOB .19 osteoblasts were assayed for ROS 
activity. At concentrations of 0.0007, 0.007, and 0.07 mg/ml, glyphosate caused no 
significant change in ROS level. ROS activity was standardized to DNA content as a 




Glutathione Activity in hFOB 1.19 Cells Chronically Exposed to Glyphosate 
 To further quantify the effect of chronic glyphosate exposure on hFOB 1.19 cells, 
glutathione (GSH) activity was assessed. It is possible that increased glutathione 
scavenges excess ROS due to glyphosate exposure. Similar to ROS, glutathione has an 
ephemeral nature, indicating that levels may vary at different time points. In the current 





















4-week chronic glyphosate exposure in all treatment groups (0.0007, 0.007, 0.07 mg/ml) 
when compared to the control group. DNA content of these cells was measured, and 
fluorescence values were standardized by DNA content to ensure equal cell number per 
treatment group. 
 
Figure 6. Levels of Intracellular Glutathione in hFOB 1.19 Cells Following Chronic 
Glyphosate Exposure. hFOB 1.19 cells were treated with 0.0, 0.0007, 0.007, and 0.07 
mg/ml glyphosate for a period of 4-weeks. Cells were plated at alow concentration in 96-
well plates. DNA content was quantified as a measure of cell number and fluorescent 
values were standardized by DNA content. The activity of glutathione (GSH) in hFOB 
1.19 human osteoblast cells shows no significant change following 4-week chronic 






























The Effects of Chronic Glyphosate Exposure on DNMT Expression and Global 
DNA Methylation 
 To analyze the potential epigenetic effects of chronic glyphosate exposure on 
hFOB 1.19 cells, qPCR analysis of the expression of genes associated with DNA 
methylation. DNMT1 and DNMT3a are part of a family of enzymes that facilitate the 
transfer of a methyl group to DNA, potentially altering gene expression; DNMT1 is 
responsible for maintaining methylation patterns, and DNMT3a is required for “de novo” 
methylation. Following 4-week exposure to glyphosate, no significant changes were 
found in the expression of DNMT1 and DNMT3a in all treatment groups (Fig. 7). 
 
 
Figure 7. Gene Expression of Epigenetic Markers in hFOB 1.19 Osteoblast Cells 
Following Chronic Glyphosate Exposure. hFOB 1.19 cells were treated with 0.0, 
0.0007, 0.007, and 0.07 mg/ml glyphosate for a period of at least 4 weeks. RNA was 
isolated, converted to cDNA, and probed for DNMT1 (A) and DNMT3a (B) transcripts 
using TaqMan® primers. Actin was used as a housekeeping gene. Values are reported 
relative to the control using the 2-ΔΔCT method. Low Level, chronic glyphosate exposure 






































































  Despite finding no significant change in DNMT expression, we sought to further 
investigate the epigenetic effect of chronic glyphosate exposure on global DNA 
methylation. The gDNA used in this experiment was extracted from hFOB 1.19 cells 
exposed for a period of at least four weeks at the experimental concentrations previously 
defined. A significant increase in global DNA methylation was only observed at our 
lowest concentration of exposure, 0.0007 mg/ml. Among the remaining treatment groups, 
no significant changes in global DNA methylation were observed relative to the control 
(Fig. 7).  
 
Figure 8. Global DNA Methylation in hFOB 1.19 Cells Chronically Exposed to 
Glyphosate. hFOB 1.19 cells were treated with 0.0, 0.0007, 0.007, and 0.07 mg/ml 
glyphosate for a period of 4-weeks prior to gDNA extraction. gDNA was quantified to 
ensure equal amounts were used for each sample. Each sample was assayed in triplicate. 
Following 4-week chronic exposure, a significant increase was observed at 0.0007 mg/ml 































Herbicide exposure has been implicated in a wide   range of human health 
problems ranging from developmental effects to cancers. More recently, there has been a 
call for greater research on the role of glyphosate exposure, the most widely used 
commercial and agricultural herbicide, on human health. In non-human organismal 
models, glyphosate has been shown to disrupt maturation in rats and fish (de Liz Oliveira 
Cavalli et al., 2013; Zebral et al., 2017) and to increase developmental abnormalities, 
including craniofacial structures and brain development in Xenopus laevis )Paganelli et 
al., 2010; Cattani et al., 2017). The potential carcinogenic effects of glyphosate exposure 
continue to be investigated and it has recently been deemed “probably carcinogenic to 
man” by the World Health Organization’s International Agency for Research on Cancer. 
Because of the widespread use of glyphosate, detectable levels have been identified in 
groundwater and precipitation as well as household consumables such as beers, wines, 
and cereals (Battaglin et al., 2014). Despite the potential hazards associated with 
glyphosate, it remains the most widely used herbicide globally, underlining the 
importance in determining the molecular effects of glyphosate exposure on human health. 
The molecular effects of glyphosate exposure are not well defined and have been 
noted to be cell type specific. A commercial formulation of glyphosate was found to 
inhibit the proliferation of human fibroblasts at environmentally relevant concentrations, 
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while increasing the proliferative rate in human breast cancer cell lines (Martini et al., 
2012; Thongprakaisang et al., 2013). It is important that we understand the effects of 
chronic glyphosate exposure on cell proliferation as it has implications in human health. 
Currently, there is little research into the molecular effects of chronic glyphosate 
exposure in human osteoblast cells. In the present study, we investigated the role of low-
level chronic glyphosate exposure over a period of four weeks.  
 
Low Level Chronic Glyphosate Exposure Enhances Osteoblast Proliferation 
We demonstrated that during a 7-day proliferation study, concentrations of 0.0007 
mg/ml and 0.007 mg/ml positively affected proliferation in hFOB 1.19 cells (Fig. 1). This 
finding is consistent with previous studies that identified glyphosate as an effector of cell 
proliferation (Martini et al., 2012; Thongprakaisang et al., 2013). While our results 
suggests that chronic glyphosate exposure is a positive effector of proliferation in human 
osteoblasts, previous studies show diverging effects on proliferation in an acute treatment 
setting. In 2012, Martini et al. showed that low level glyphosate exposure to glyphosate 
can inhibit proliferation fibroblast cells. In contrast, Throngprakaisang et al. 
demonstrated that low level glyphosate exposure caused an increase in cell proliferation 
in breast cancer cells, indicating that the effect may be cell line dependent. One potential 
consequence of enhanced osteoblast proliferation is an increase in osteoblast population 




Low Level Chronic Glyphosate Exposure Enhances Osteoblast Differentiation 
We also investigated the effects of chronic glyphosate exposure on the expression 
of three genes associated with human osteoblast differentiation: Osterix, RUNX2, and 
Osteocalcin. RUNX2 and osterix are transcription factors required for determination of 
the osteoblast lineage and are typically early markers for osteoblast differentiation. We 
report no significant difference in the expression of these genes relative to the control 
(Fig 3A-B). Osteocalcin is a protein that is uniquely secreted by osteoblasts and is 
typically found to increase as these cells differentiate. While we saw no significant 
difference between our treatment groups and our control, we saw a trending increase in 
osteocalcin expression at our lowest concentration of exposure, 0.0007 mg/ml (Fig. 3C-
D). Further replications of this study will be necessary to determine if this trend is 
significant. If so, the results would suggest that chronic glyphosate exposure enhances 
osteoblast differentiation. 
We further categorized glyphosates effect on differentiation by measuring 
alkaline phosphatase (ALP) activity. ALP is considered to be one of the most commonly 
accessible identifiers of osteoblast differentiation (Hashemibeni et al., 2013). ALP is 
expressed early in the differentiation process and is necessary for the mineralization of 
bone (Jafary et al., 2017). It reasons that greater ALP activity has greater potential to 
impact bone formation. Here, we report a dose-dependent effect on hFOB 1.19 ALP 
activity at Day 7 of osteoblastic differentiation, whereas the lowest concentration of 
glyphosate seems to cause the greatest increase in ALP activity (Fig. 2). Despite seeing 
no significant changes in the expression of our differentiation associated genes, a 
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significant increase in ALP activity was detected at Day 7 of osteogenesis, suggesting 
that chronic glyphosate exposure enhances osteoblast differentiation. It is possible that if 
RUNX2 and Osterix are not effected by glyphosate, that it is possible that the effect on 
differentiation is a result of glyphosate effecting the ALP and Osteocalcin genes 
themselves. Furthermore, it is plausible that the effect could be epigenetic. We observed 
increased methylation at 0.0007 mg/ml in our 5-mC ELISA assay. Previous studies have 
indicated that the Osteocalcin promotor is susceptible to epigenetic modification, thus 
effecting osteoblast differentiation (Villagra et al., 2002). 
We also analyzed osteoblast differentiation at 21 days post-induction. At this 
time, osteoblasts should be fully differentiated into osteocytes and secreting bone matrix. 
Using the Alizarin Red assay, the amount of mineralization was compared. In this study, 
we allowed our chronically treated osteoblasts to differentiate for a period of 21 days. 
Similar to ALP activity, we noted a significant increase in mineralization at 0.0007 and 
0.007 mg/ml glyphosate (Fig. 4). These data indicate that chronic glyphosate causes an 
increase in osteoblastic maturation as early as 7 days into the differentiation process, 
which was reflected at late stage differentiation.  
 
No Effect of Chronic Glyphosate Exposure on Osteoblast ROS or Glutathione 
Levels 
Literature suggests that glyphosate exposure can alter cellular ROS production, 
some of which are at levels well below agricultural recommendations (Bailey et al., 
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2018; Chaufan et al., 2014]. Chaufan et al. reported that glyphosate exposure caused a 
dose-dependent increase in oxidative stress at concentrations as low as 0.04 mg/ml, much 
lower than what would commonly be found in agricultural products. The concentrations 
in our study range from 0.0007 to 0.07 mg/ml glyphosate. We reported no change in ROS 
activity in hFOB 1.19 cells following chronic glyphosate exposure. Glyphosate is 
available in many formulations. While the studies above used commercial formulations 
of glyphosate acid, our study investigated concentrated glyphosate in ddH2O, possibly 
indicating the differences in results. 
Antioxidants serve a critical role in cellular redox balancing. As oxidative stress 
mounts in a cell, the expression of antioxidants, such as glutathione, increases 
accordingly to return intracellular ROS to a basal level. Previously mentioned studies 
indicated that glyphosate exposure alters levels of cellular ROS, which could potentially 
alter cellular glutathione levels. Evaluation of hFOB 1.19 cells chronically exposed for 4 
weeks to low levels of glyphosate showed no significant change in glutathione levels 
(Fig. 6). Xenobiotic compounds are known to induce oxidative stress (Henkler et al., 
2010). A potential explanation for these data could be indicated by the ephemeral nature 
of ROS and glutathione. There is the possibility that these cells have adapted to the 
increased environmental stress and are well suited to deal with the increased ROS 





Low Level, Chronic Glyphosate Exposure Enhances Global DNA Methylation; No 
Effect on DNMT Expression 
As previously indicated, a byproduct of increased oxidative stress is the 
modification of DNA methylation (5-mC) patterns. The most common epigenetic 
variance in cancer cells is abnormal DNA methylation patterns. Recent studies have 
shown that demethylation in glioma tissue was a direct result of increased reaction of 
hydroxyl radicals with DNA (Barciszewska et al., 2019), however this effect has not been 
investigated in osteoblastic cells. Smith et al. (2019) have shown that glyphosate leads to 
a decrease in the expression of DNA methyltransferase in a fish model. Generally, DNA 
methyltransferase proteins work to catalyze the transfer of methyl groups to DNA, 
though the epigenetic effects of glyphosate are sparsely documented. In the present study, 
we show that the expression of DNMT1 and DNMT3a show no significant change 
following chronic glyphosate exposure in human osteoblast cells (Fig. 7). Though DNMT 
expression remains unchanged, glyphosate still has the potential to alter the epigenome. 
The methylcytosine dioxygenase (TET) genes function to remove methyl groups from 
DNA and have been noted to increase following glyphosate exposure in previous studies 
(Smith et al., 2019). Further gene expression analysis is required on osteoblasts to 
determine if the effect is seen in our cell line. 
Experimental studies have shown altered epigenetic marks such as changes in 
global DNA methylation in response to glyphosate exposure. Hypomethylation has been 
documented in human peripheral blood mononuclear cells as a byproduct of acute 
glyphosate exposure (Woźniak et al., 2020). Despite a shorter treatment period, this study 
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found a significant decrease in global DNA methylation in response to low-level 
glyphosate exposure. Our present study investigated the effects of chronic low-level 
exposure on global 5-mC. Human osteoblasts were differentiated in the presence of 
glyphosate for 21-days prior to assay. We found a significant increase in global DNA 
methylation at 0.0007 mg/ml relative to the control (Fig. 8). No significant changes were 
observed in the remaining treatment groups. These results are in contrast with many 
studies that previously discussed. A possible explanation would be the use of differing 
cell types. Another important consideration is that measurements of global methylation 
do not reveal sequence specific methylation changes. Increased methylation within gene 
promoter CpG islands could affect gene expression, whereas in other genomic locations, 
such changes may have no effect. DNA methylation and epigenetic patterning is a 
complex process and is known to vary within cell populations of the same type (Rakyan 
et al., 2008). Though these data indicate that chronic glyphosate exposure has no effect 
on the expression of DNMTs, which are responsible for  DNA methylation patterning in 
human osteoblasts, additional studies on TET gene expression would be beneficial for 
confirming the epigenetic effects of chronic glyphosate exposure. In addition, analysis of 
sequence-specific DNA methylation and gene expression using RNAseq analysis in 
chronically glyphosate exposed cells would provide a more complete understanding of 
the possible epigenetic effects of glyphosate exposure. Interpretation of these data need to 
take into consideration the complex nature of cellular epigenetics. 
The effects of glyphosate exposure are varied and depend on cell type, length of 
exposure, and concentration. The chronic effects of glyphosate exposure are not well 
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documented. In the present study, we have shown that chronic low-dose glyphosate 
exposure has a positive effect on hFOB 1.19 proliferation. The lowest two levels of 
exposure in our study (0.0007 and 0.007 mg/ml) had the greatest enhancing effect on 
proliferation, ALP activity, and bone mineralization. The lowest level of exposure 
(0.0007 mg/ml) showed the greatest significant increase on global DNA methylation. 
Similarly, we also saw a trending enhancement of Osteocalcin expression, though not at a 
significant level. It was common throughout our study that the greatest effects of 
glyphosate exposure occurred at the lowest concentrations of exposure, including the 
EPA acceptable limit of 0.0007 mg/ml. Hence, environmentally relevant concentrations 
have the potential to alter bone dynamics by increasing osteoblasts and enhancing 
differentiation. This study provides insight into the effects of chronic glyphosate 
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